<h1>History of SMPV</h1>

<ul class="list-group list-group-flush">
  <li class="list-group-item">
<span class="badge badge-primary badge-pill">2011</span>
Mr. Shuwei Zong and colleagues started ginseng peptide research and development.
  </li>
  <li class="list-group-item">
<span class="badge badge-primary badge-pill">2012</span>
Mr. Shuwei Zong co-founded Jilin TaiGu (Peptide Valley) Bioengineering Co. (the predecessor of SMPV).
  </li>
  <li class="list-group-item">
<span class="badge badge-primary badge-pill">2014</span>
Jilin TaiGu built 15,000 square meters (3.7 acres) facility with two automatic production lines with proprietary technology to process natural plants such as ginseng into the form of peptides.
  </li>
  <li class="list-group-item">
<span class="badge badge-primary badge-pill">2014</span>
Jilin TaiGu started to collaborate with Peking University Health Science Center to conduct 24 ginseng peptide related research projects.
  </li>
  <li class="list-group-item">
<span class="badge badge-primary badge-pill">2015</span>
Jilin Peptide Bioengineering Co., Ltd. was grated the Innovative Patent "Extraction Method for Ginseng Peptide" (ZL201510622841.0).
  </li>
  <li class="list-group-item">
<span class="badge badge-primary badge-pill">2017</span>
With strategic investment from Sinopharm Group Co., Ltd, Jilin TaiGu Bioengineering Co. was merged into Guoyao TaiGu (SinoMed Peptide Valley).
  </li>
</ul>
